Zymeworks (ZYME) Cash from Financing Activities (2021 - 2026)

Zymeworks (ZYME) has 6 years of Cash from Financing Activities data on file, last reported at $178.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 13485.56% year-over-year to $178.8 million; the trailing twelve-month figure through Mar 2026 stood at $158.9 million (up 847.78% YoY), and the FY2025 full-year result was -$18.6 million, up 9.19% from the prior year.
• Cash from Financing Activities improved to $178.8 million in Q1 2026, from -$18.7 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $178.8 million in Q1 2026 to a low of -$18.7 million in Q4 2025.
• A 5-year average of $19.4 million and a median of $1.3 million in 2025 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities jumped 13530.24% in 2023 and plunged 889.87% in 2024, its largest moves.
• Tracing ZYME's Cash from Financing Activities over 5 years: stood at -$377000.0 in 2022, then jumped by 13530.24% to $50.6 million in 2023, then slumped by 117.07% to -$8.6 million in 2024, then plunged by 116.87% to -$18.7 million in 2025, then surged by 1053.93% to $178.8 million in 2026.
• Business Quant data shows ZYME's Cash from Financing Activities at $178.8 million in Q1 2026, -$18.7 million in Q4 2025, and -$2.5 million in Q3 2025.